Long Focus Capital Management, LLC Bicycle Therapeutics PLC Transaction History
Long Focus Capital Management, LLC
- $2.94 Billion
- Q4 2024
A detailed history of Long Focus Capital Management, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 543,092 shares of BCYC stock, worth $6.82 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
543,092Holding current value
$6.82 Million% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
103Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$137 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$57.2 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$43.3 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$32.8 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$27.6 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $372M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...